NeuroBo Pharmaceuticals (NRBO)
(Real Time Quote from BATS)
$4.65 USD
+0.05 (1.09%)
Updated May 17, 2024 02:08 PM ET
NA Value
NA Growth NA Momentum NA VGMDetailed Estimates
EPS Estimates
Exp Earnings Date | 8/14/24 |
---|---|
Current Quarter | -0.95 |
EPS Last Quarter | -1.32 |
Last EPS Surprise | -38.95% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -3.50 |
Next Year | -2.22 |
EPS (TTM) | NA |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.95 | -0.97 | -3.50 | -2.22 |
# of Estimates | 1 | 1 | 2 | 2 |
Most Recent Consensus | -0.95 | -0.97 | -3.83 | -2.59 |
High Estimate | -0.95 | -0.97 | -3.17 | -1.85 |
Low Estimate | -0.95 | -0.97 | -3.83 | -2.59 |
Year ago EPS | -0.16 | -0.72 | -2.46 | -3.50 |
Year over Year Growth Est. | -493.75% | -34.72% | -42.28% | 36.57% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 1 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 1 | 1 |
Down Last 60 Days | 0 | 0 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.95 | -0.97 | -3.50 | -2.22 |
7 Days Ago | -0.95 | -0.97 | -3.50 | -2.22 |
30 Days Ago | NA | NA | -3.00 | -1.90 |
60 Days Ago | NA | NA | -3.26 | -1.94 |
90 Days Ago | NA | NA | -3.26 | -1.94 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.95 | -0.97 | -3.83 | -2.59 |
Zacks Consensus Estimate | -0.95 | -0.97 | -3.50 | -2.22 |
Earnings ESP | 0.00% | 0.00% | -9.43% | -16.67% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.32 | NA | -0.72 | -0.16 | NA |
Estimate | -0.95 | NA | NA | NA | NA |
Difference | -0.37 | NA | NA | NA | -0.37 |
Surprise | -38.95% | NA | NA | NA | -38.95% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more